benefit of two of the newer drugs for osteoporosis

There's good news about the benefit of two of the newer drugs for osteoporosis...Evista (raloxifene) and Fosamax (alendronate).

Evista is a selective estrogen receptor modulator (SERM). Lilly markets it now in the U.S...soon in Canada.

Evista has now been shown to prevent FRACTURES...initially it was shown just to increase bone density.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote